Biogen (BIIB) option IV into Clinical Trials on Alzheimer's Congress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 235.35 +2.52 (1.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $232.83 | 52 Week High | $333.65 | |||
| Open | $236.46 | 52 Week Low | $223.02 | |||
| Day High | $240.99 | P/E | 30.13 | |||
| Day Low | $235.22 | EPS | $7.81 | |||
| Volume | 1,572,437 | |||||
